Alcon

CIO Leadership: Celebrating Charlie Feld and Other Recipients of HMG Strategy’s Global Leadership Institute Awards at the 15th Annual Dallas C-Level Technology Leadership Summit on April 2

Retrieved on: 
Thursday, March 28, 2024
Cloud, CIO, D.C, Partner, Automation, Organization, HMG, Security guard, Box, Business, First Data, Alcon, Frito-Lay, SIM, Data, BNSF Railway, EDS, BetterCloud, SAP, Transformation, RingCentral, LINX, Akamai Technologies, Zoom, Computer security, Fortinet, Automation Anywhere, Intelligent automation, Delta Air Lines, Pure Storage, LastPass, Management

“In 2024, our recognition program will honor elite global technology, business and search leaders whose teams are delivering unparalleled value to their organizations.

Key Points: 
  • “In 2024, our recognition program will honor elite global technology, business and search leaders whose teams are delivering unparalleled value to their organizations.
  • For more information about the 15th Annual C-Level Dallas Technology Leadership Summit and to register, click here .
  • HMG Strategy is also excited to be hosting its 13 th Annual Washington, D.C. C-Level Technology Leadership Summit on April 18 at the Ronald Reagan Building.
  • To learn more about the 13th Annual Washington, D.C. C-Level Technology Leadership Summit and to register for the event, click here .

CIO Leadership: The Call for Cybersecurity Innovation will Power the Discussion at the 13th Annual Washington, D.C. C-Level Technology Leadership Summit on April 18

Retrieved on: 
Friday, March 22, 2024
Cloud, KPMG, Schneider Electric, Box, Atlantic Health System, CISO, Imperial Bank of China, Zoom, CIO, HMG, Alcon, RingCentral, Bimbo Bakeries USA, Vishal Dadlani, Commercial bank, LastPass, Automation, Security guard, EVP, Digital, Data, BetterCloud, SAP, Computer security, Fortinet, Npower, SIM, Transformation, LINX, Automation Anywhere, Intelligent automation, Management

To learn more about the 17th Annual New York CIO Summit of America and to register for the event, click here .

Key Points: 
  • To learn more about the 17th Annual New York CIO Summit of America and to register for the event, click here .
  • HMG Strategy will also be hosting its 15 th Annual Dallas C-Level Technology Leadership Summit on April 2.
  • Key topics to be explored at the event will include opportunities to leverage innovative technologies and partnerships to power business growth.
  • For more information about the 15th Annual C-Level Dallas Technology Leadership Summit and to register, click here .

CIO Leadership: The Call for Visionary Global Leadership Will Power the Discussion at HMG Strategy’s 17th Annual New York CIO Summit of America on April 11

Retrieved on: 
Tuesday, March 12, 2024
Cloud, KPMG, Schneider Electric, Box, Atlantic Health System, CISO, Engineering, Imperial Bank of China, Zoom, Information system, CIO, HMG, Alcon, RingCentral, Bimbo Bakeries USA, LastPass, Commercial bank, Automation, Organization, Arizona State University, Security guard, EVP, Digital, Data, BetterCloud, SAP, Computer security, Fortinet, Npower, OpenText, SIM, Transformation, FPT Corporation, Automation Anywhere, Cox Communications, Intelligent automation, Management

“There’s never been a better time to be an enterprise business technology executive,” said Hunter Muller, Founder and CEO of HMG Strategy.

Key Points: 
  • “There’s never been a better time to be an enterprise business technology executive,” said Hunter Muller, Founder and CEO of HMG Strategy.
  • To learn more about the 17th Annual New York CIO Summit of America and to register for the event, click here .
  • To learn more about the 15th Annual Phoenix C-Level Technology Leadership Summit and to register for the event, click here .
  • HMG Strategy will also be hosting its 15 th Annual Dallas C-Level Technology Leadership Summit on April 2.

Tilak Healthcare Strengthens Its Leadership Team

Retrieved on: 
Tuesday, March 19, 2024
Biotechnology, Human Resources, Optical, Finance, Health, Health Technology, Professional Services, Other Health, Retina, Social Security, Conditional sentence, HEC Paris, Euronext Growth, CFO, Partnership, Knowledge, Health care, Information, University, Prescription, Head, Visual impairment, Laboratory, ParisTech, Drug, Alcon, Social, Genomics, Pharmacy, Directorate, Multimedia, Ministry, Doctorate

Tilak Healthcare, a leading company in digital health for the monitoring of chronic eye diseases, announces the appointment of three experts to support the leadership team, currently composed of Edouard Gasser (CEO & co-founder), Philip Bouchet (Chief Operating and Product Officer), and Dr. Bénigne Mathieu (Chief Business Officer).

Key Points: 
  • Tilak Healthcare, a leading company in digital health for the monitoring of chronic eye diseases, announces the appointment of three experts to support the leadership team, currently composed of Edouard Gasser (CEO & co-founder), Philip Bouchet (Chief Operating and Product Officer), and Dr. Bénigne Mathieu (Chief Business Officer).
  • For Benoît Gueugnon, CFO: "I would like to thank the management team as well as the investors of Tilak Healthcare (iBionext, Elaia, Swen Capital, Matmut, Caphorn, and Laboratoires Théa).
  • For Dr. Patricia Zilliox: "I am impressed by Tilak Healthcare's journey, establishing itself as a leader in digital health in ophthalmology.
  • Undoubtedly, these achievements and the quality of the team are undeniable assets for approaching the American market."

Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Appoints Renowned Oculoplastic Surgeon, John P. Fezza, MD to Its Medical Advisory Board

Retrieved on: 
Thursday, March 14, 2024
Biotechnology, Surgery, Health, Pharmaceutical, Optical, MAB, Drainage, Alcon, Private practice, Telecanthus, Patient, Bausch & Lomb, MBA, Ophthalmology, Optometry, FDA, Pharma, Pharmaceutical industry

Dr. Fezza joins the MAB as Nordic Pharma prepares to launch a novel therapy for Dry Eye Disease, LACRIFILL® Canalicular Gel.

Key Points: 
  • Dr. Fezza joins the MAB as Nordic Pharma prepares to launch a novel therapy for Dry Eye Disease, LACRIFILL® Canalicular Gel.
  • The FDA-cleared, cross-linked hyaluronic acid derivative LACRIFILL is intended to temporarily block tear drainage by the occlusion of the canalicular system.
  • “The entire U.S. Medical Advisory Board of Nordic Pharma is honored and delighted to welcome John Fezza, MD, a world class oculoplastic surgeon to our MAB,” said Eric Donnenfeld, MD, MAB Chair.
  • Nordic Pharma is committed to engaging ophthalmologists and optometrists in the early launch stages of LACRIFILL Canalicular Gel.

Beyeonics Vision Appoints A. Burton Tripathi, PhD, as CEO

Retrieved on: 
Thursday, March 28, 2024
McKinsey & Company, Growth, Mechanical engineering, Alcon, Cornell University, Sale, Medical device, Doctor of Philosophy, Bachelor, Truevision, Intuitive Surgical, Microsurgery, Health, Medtech, Management

This strategic decision marks a pivotal moment for Beyeonics Vision as it reaffirms the commitment to advancing technological breakthroughs in the fields of Ophthalmology and prepares for its next phase of growth.

Key Points: 
  • This strategic decision marks a pivotal moment for Beyeonics Vision as it reaffirms the commitment to advancing technological breakthroughs in the fields of Ophthalmology and prepares for its next phase of growth.
  • Having recently served as CEO of TrueVision Systems Inc., he concluded the sale and integration of TrueVision with Alcon.
  • In his new role as CEO of Beyeonics Vision, Dr. Tripathi will lead the company's strategic direction, driving innovation and propelling the organization forward in its mission to revolutionize patient care in ophthalmology.
  • Yoram Shmuely, chairman of the Beyeonics Vision board, commented on the appointment, stating, "We believe Mr. Tripathi's leadership will continue to drive innovation and push forward Beyeonics Vision into the market.

EyePoint Pharmaceuticals Announces Appointment of Ramiro Ribeiro, M.D., Ph.D. as Chief Medical Officer

Retrieved on: 
Monday, March 4, 2024
Therapy, Ophthalmology, Digital health, New Drug Application, Alcon, Pontifical university, Retina, FDA, Geographic atrophy, University of Southern California, Safety, Compensated emancipation, University, Patient, Employment, Drug, NDA, Research

WATERTOWN, Mass., March 04, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced the appointment of Ramiro Ribeiro, M.D., Ph.D. as Chief Medical Officer to succeed Dario Paggiarino, M.D. who has served as EyePoint’s Chief Medical Officer since 2016. Dr. Ribeiro is a trained retinal specialist and joins EyePoint from Apellis Pharmaceuticals, where he served as Vice President, Head of Clinical Development.

Key Points: 
  • who has served as EyePoint’s Chief Medical Officer since 2016.
  • Dr. Ribeiro is a trained retinal specialist and joins EyePoint from Apellis Pharmaceuticals, where he served as Vice President, Head of Clinical Development.
  • “Ramiro is a proven leader with a strong scientific and clinical background, and a track record of successfully bringing novel therapies for patients.
  • I also want to express my sincere gratitude to Dr. Paggiarino for his numerous contributions to EyePoint during his tenure.

CIO Leadership: HMG Strategy to Recognize Five Exemplary Global Leadership Institute Award Winners at its 15th Annual Phoenix C-Level Technology Leadership Summit on March 21

Retrieved on: 
Friday, February 16, 2024
Cloud, Creatio, Security guard, Computer security, BetterCloud, Transformation, Organization, Automation, SentinelOne, Cox Communications, HMG, OpenText, Alcon, Box, SVP, FPT Corporation, CISO, Arizona State University, CIO, RingCentral, SAP, Automation Anywhere, Zoom, Information system, SIM, Intelligent automation, Fortinet, Data, Berkshire Hathaway, LastPass, Management

HMG Strategy’s 2024-2025 Global Leadership Institute Awards recognize the industry’s premier business technology executives who are making a difference in their organizations and their respective vertical market.

Key Points: 
  • HMG Strategy’s 2024-2025 Global Leadership Institute Awards recognize the industry’s premier business technology executives who are making a difference in their organizations and their respective vertical market.
  • To learn more about the 15th Annual Phoenix C-Level Technology Leadership Summit and to register for the event, click here .
  • HMG Strategy will also be hosting its 15th Annual Dallas C-Level Technology Leadership Summit on April 2.
  • For more information about the 15th Annual C-Level Dallas Technology Leadership Summit and to register, click here .

Ace Vision Group Names Val Kolesnitchenko, MD as Chief Scientific Officer

Retrieved on: 
Tuesday, February 13, 2024
Ophthalmology, Alcon, Research, FDA, Presbyopia, Ageing, Bausch & Lomb, Eye, Executive, Patient, Disease, Val, Science, Bausch, LSM, Medical device

BOSTON, Feb. 13, 2024 /PRNewswire/ -- Ace Vision Group, Inc., an emerging medical device company at the forefront of pioneering rejuvenation therapy for the aging eye and presbyopia, announced that it has named Val Kolesnitchenko, MD, as Chief Scientific Officer.

Key Points: 
  • BOSTON, Feb. 13, 2024 /PRNewswire/ -- Ace Vision Group, Inc., an emerging medical device company at the forefront of pioneering rejuvenation therapy for the aging eye and presbyopia, announced that it has named Val Kolesnitchenko, MD , as Chief Scientific Officer.
  • "Dr. Kolesnitchenko has a strong foundation in both surgical and therapeutic ophthalmology, as well as highly developed interpersonal skills and industry relationships," said Dr. AnnMarie Hipsley, CEO of Ace Vision Group.
  • Val's assignment to the company as Chief Scientific Officer comes at a very timely period in the company's preparations for its medical device regulatory submissions.
  • "I look forward to working with Ace Vision Group on this revolutionary approach to presbyopia," said Dr. Kolesnitchenko.

Insulet Announces Changes to Board of Directors with Retirements and New Appointments

Retrieved on: 
Thursday, January 18, 2024
Medical Supplies, Health, Medical Devices, Diabetes, Health Technology, General Health, Biotechnology, Corporation, Medical device, Alcon, Business administration, University, Santa Clara University, HPE, Johnson & Johnson, General Electric, Hewlett Packard Enterprise, Management

In addition, the Company announced Shacey Petrovic and Corinne Nevinny will retire from the Board during the Company’s 2024 Annual Meeting in May.

Key Points: 
  • In addition, the Company announced Shacey Petrovic and Corinne Nevinny will retire from the Board during the Company’s 2024 Annual Meeting in May.
  • “We are excited to welcome Flavia and Tim to the Insulet Board,” said Timothy Scannell, Chairman of Insulet’s Board of Directors.
  • “They are both highly respected leaders who have had distinguished careers and critical leadership roles in prominent corporations.
  • She joined Charles River in 2022 as Corporate Executive Vice President and Chief Financial Officer where she leads the Finance and Procurement Functions.